Public Employees Retirement System of Ohio Makes New Investment in Haleon PLC Sponsored ADR $HLN

Public Employees Retirement System of Ohio purchased a new stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 773,503 shares of the company’s stock, valued at approximately $7,217,000.

Several other large investors have also made changes to their positions in HLN. Morgan Stanley boosted its stake in shares of Haleon by 16.0% in the fourth quarter. Morgan Stanley now owns 21,495,383 shares of the company’s stock worth $217,318,000 after acquiring an additional 2,962,856 shares during the period. Norges Bank bought a new stake in Haleon during the 4th quarter valued at approximately $163,529,000. Arrowstreet Capital Limited Partnership lifted its holdings in Haleon by 82.8% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 14,674,518 shares of the company’s stock worth $146,892,000 after purchasing an additional 6,647,329 shares in the last quarter. Bank of America Corp DE lifted its holdings in Haleon by 116.7% in the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after purchasing an additional 6,669,923 shares in the last quarter. Finally, Sculptor Capital LP boosted its stake in Haleon by 5.1% in the 4th quarter. Sculptor Capital LP now owns 10,454,868 shares of the company’s stock worth $105,699,000 after purchasing an additional 505,000 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Trading Up 0.6%

Shares of HLN opened at $10.09 on Wednesday. The stock has a market capitalization of $44.38 billion, a PE ratio of 25.87, a P/E/G ratio of 2.01 and a beta of 0.12. The company’s fifty day moving average is $9.85 and its 200 day moving average is $9.78. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.52 and a current ratio of 0.69. Haleon PLC Sponsored ADR has a fifty-two week low of $8.65 and a fifty-two week high of $11.28.

Haleon Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, September 17th. Shareholders of record on Friday, August 14th will be paid a $0.0642 dividend. This represents a dividend yield of 132.0%. The ex-dividend date of this dividend is Friday, August 14th. Haleon’s dividend payout ratio (DPR) is presently 30.77%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a report on Sunday, July 12th. Morgan Stanley restated an “overweight” rating on shares of Haleon in a research report on Thursday, August 6th. Rothschild & Co Redburn cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Jefferies Financial Group reiterated a “buy” rating on shares of Haleon in a research note on Monday, August 24th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.